about
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansionDecoding human cytomegalovirusHuman cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and IIIExploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization.Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells.MicroRNA editing facilitates immune elimination of HCMV infected cells.The Transcription and Translation Landscapes during Human Cytomegalovirus Infection Reveal Novel Host-Pathogen Interactions.Mouse newborn cells allow highly productive mouse cytomegalovirus replication, constituting a novel convenient primary cell culture system.Broad and potent antiviral activity of the NAE inhibitor MLN4924.Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention.Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses.Checks and balances between human cytomegalovirus replication and indoleamine-2,3-dioxygenase."Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling.Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes.Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation.Human Cytomegalovirus-Induced Degradation of CYTIP Modulates Dendritic Cell Adhesion and Migration.Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus.MAPKAP kinase 2 regulates IL-10 expression and prevents formation of intrahepatic myeloid cell aggregates during cytomegalovirus infections.HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2.The Canonical Immediate Early 3 Gene Product pIE611 of Mouse Cytomegalovirus Is Dispensable for Viral Replication but Mediates Transcriptional and Posttranscriptional Regulation of Viral Gene ProductsDynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK CellsDeciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression.Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts.STAT2-dependent immune responses ensure host survival despite the presence of a potent viral antagonist.The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell AttackA Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded VpxCellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegalovirusesm6A modification controls the innate immune response to infection by targeting type I interferonsHLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection
P50
Q28251295-6CB08DB5-FE8D-468C-951E-E40C31C942A5Q28279933-564DCCC4-A7F9-4502-8CAD-8904AB0F5D5FQ33618817-2FE67415-1473-449C-A4C4-19ACF3119966Q33802555-2FC191A4-2489-41CA-8598-66DC3292422DQ33941023-9B1DF5CE-ED73-41F6-8CE9-3DBD63827CD2Q35105657-87FEF0CF-008E-4F62-810E-29D3776F50EFQ35850190-8076439D-C82B-4C9A-9C81-D49549617947Q36322086-CFA8B628-805F-490C-A77C-8CD1390280ECQ36524801-D0E16B7D-B794-490B-97F5-8C580C047041Q38052946-7374A156-E327-40FE-B369-38DCA8CFDFA5Q38523847-C3705C95-8382-457C-9184-76CEFFAEFD30Q39043502-10C71422-27F2-40B7-AEBA-473D0E2E2CE9Q39045238-FCA24BD2-64DA-4F4C-BCD5-DE36AD08DAC1Q39462585-CEF4FAFD-D777-426E-89AB-1148379564DFQ39773021-4B1EEA23-0671-453B-9A62-8B7D420739A7Q39939124-5689CE8F-F68C-4D49-BFEF-81B2F3806930Q40209543-9B39E7AC-DCB4-4F58-9A1A-E508450D7119Q40469638-5311F087-7B0A-4C94-8703-F505F1E9B68EQ40615418-5C3AC6F4-D16E-4F20-9C6F-ABEE0D3B1F96Q40681668-EADEC3C6-EFD7-413A-BFFA-8AF537875C83Q41170179-3C9E7D7A-9452-47C8-934F-A0B903DC0288Q41482457-3857C678-945A-4D85-ACDB-45359E767210Q41673056-1D6DDA36-F4BA-4CB0-A418-C1D6A44EDC8EQ41989639-6318FC1F-B8A4-4548-8BDE-8AF8B30D523DQ54216757-0DD8612B-EF9F-44D3-98AC-6CEB786FD132Q55072526-C35DEC01-15AC-44F5-A8F5-C3DC37747609Q57169061-130EF7BC-4417-4288-A919-CBFB4210706EQ60947014-C434E6E4-50AC-4BAA-9DB3-AA634AF30102Q63740305-86F59B6D-9EBC-4EAF-9C75-669AAAF55985Q67200928-F1566B32-13CF-4283-AFF6-D09AE72C327CQ90135524-D1B6A0C0-EA47-4C96-84A2-EB387575F6DEQ90375083-F4784732-81B5-4716-9C9D-9F0CEAF5B9B2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vu Thuy Khanh Le
@ast
Vu Thuy Khanh Le
@en
Vu Thuy Khanh Le
@es
Vu Thuy Khanh Le
@nl
Vu Thuy Khanh Le
@sl
type
label
Vu Thuy Khanh Le
@ast
Vu Thuy Khanh Le
@en
Vu Thuy Khanh Le
@es
Vu Thuy Khanh Le
@nl
Vu Thuy Khanh Le
@sl
altLabel
Khanh Le-Trilling
@en
Vu Thuy Khanh Le
@en
prefLabel
Vu Thuy Khanh Le
@ast
Vu Thuy Khanh Le
@en
Vu Thuy Khanh Le
@es
Vu Thuy Khanh Le
@nl
Vu Thuy Khanh Le
@sl
P106
P2798
P31
P496
0000-0002-2733-3732